...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Thoughts on ZCC

"Your broker could probably answer that as to whether they would allow it or not if they are already allowing Zenith shares in your non-registered accounts."

RVXOT, I'm of the same premise.

Best to let sleeping dogs lie!

 

Koo

Share
New Message
Please login to post a reply